Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lebrikizumab OCS-sparing in severe asthma
NCT01987492Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 16
01
Overview
A Phase 2 trial of lebrikizumab in asthma, sponsored by Roche. Started Feb 2014; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01987492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987492.